Back to Journals » OncoTargets and Therapy » Volume 13

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway

Total article views   HTML views PDF downloads Totals
4,904 Dovepress* 4,517+ 756 5,273
PubMed Central* 387 101 488
Totals 4,904 857 5,761
*Since 17 August 2020

View citations on PubMed Central and Google Scholar